TisagenlecleucelCytokine release syndrome and immune related effector cell-associated neurotoxicity syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1959卷 / 1期

关键词：

D O I：

10.1007/s40278-023-40780-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：608 / 608

相关论文

共 50 条

[1] TisagenlecleucelCytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2023, 1944 (1) : 526 - 526
[2] TisagenlecleucelCytokine release syndrome and immune effector cell-associated neurotoxicity: 2 case reports
Reactions Weekly, 2023, 1970 (1) : 260 - 260
[3] TisagenlecleucelCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1946 (1) : 515 - 515
[4] PembrolizumabCytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2024, 2028 (1) : 430 - 430
[5] TisagenlecleucelCytokine release syndrome and immune effector cell associated neurotoxicity syndrome: 2 case reports
Reactions Weekly, 2025, 2041 (1) : 384 - 384
[6] Ipilimumab/nivolumabCytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2025, 2043 (1) : 203 - 203
[7] AntineoplasticsCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: case report
Reactions Weekly, 2023, 1952 (1) : 66 - 66
[8] Axicabtagene-ciloleucelCytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2023, 1986 (1) : 81 - 81
[9] AntineoplasticsLack of efficacy, cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2022, 1934 (1) : 48 - 48
[10] TeclistamabCytokine release syndrome and immune effector cell-associated neurotoxicity syndrome
Reactions Weekly, 2024, 1998 (1) : 442 - 442

← 1 2 3 4 5 →